Literature DB >> 16079042

Insomnia.

Chien-Ming Yang1, Arthur J Spielman, Yu-Shu Huang.   

Abstract

The pathogenesis of insomnia in an individual usually is multifaceted. Effective treatments require a thorough evaluation to determine the factors that need to be addressed. Pharmacologic treatments generally are safe and effective for short-term use. Long-term hypnotic use remains controversial because of the potential risk of tolerance and dependency. Various cognitive and behavioral treatments for insomnia have been shown to be effective in the management of insomnia. For long-term follow-up, multicomponent cognitive behavioral therapy, alone or in combination with hypnotic use, has been shown to be superior to hypnotic use alone.

Entities:  

Year:  2005        PMID: 16079042     DOI: 10.1007/s11940-005-0030-2

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.972


  58 in total

1.  Age differences in sleep-wake behavior under natural conditions.

Authors:  C J Kramer; G A Kerkhof; W F Hofman
Journal:  Pers Individ Dif       Date:  1999

2.  EEG power spectra in sleep-onset insomnia.

Authors:  R R Freedman
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1986-05

3.  A preliminary study comparing sleep restriction and relaxation treatments for insomnia in older adults.

Authors:  L Friedman; D L Bliwise; J A Yesavage; S R Salom
Journal:  J Gerontol       Date:  1991-01

4.  Treating psychophysiologic insomnia with biofeedback.

Authors:  P Hauri
Journal:  Arch Gen Psychiatry       Date:  1981-07

5.  Hypnotic activity of melatonin.

Authors:  B M Stone; C Turner; S L Mills; A N Nicholson
Journal:  Sleep       Date:  2000-08-01       Impact factor: 5.849

Review 6.  Pharmacologic management of insomnia.

Authors:  James K Walsh
Journal:  J Clin Psychiatry       Date:  2004       Impact factor: 4.384

7.  Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia.

Authors:  Michael L Perlis; W Vaughn McCall; Andrew D Krystal; James K Walsh
Journal:  J Clin Psychiatry       Date:  2004-08       Impact factor: 4.384

Review 8.  Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound.

Authors:  Guy Chouinard
Journal:  J Clin Psychiatry       Date:  2004       Impact factor: 4.384

Review 9.  Zolpidem 'as needed': methodological issues and clinical findings.

Authors:  Raymond Cluydts
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

10.  Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?

Authors:  D E Ford; D B Kamerow
Journal:  JAMA       Date:  1989-09-15       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.